Navigation Links
DecisionView to Create Clinical Trial Enrollment Benchmarks
Date:6/16/2011

SAN FRANCISCO, June 16, 2011 /PRNewswire/ -- DecisionView Inc., a leading provider of software solutions to optimize clinical trial enrollment for life sciences companies, today announced that a number of pharmaceutical industry leaders including GlaxoSmithKline and Roche have agreed to participate in the creation of a set of industry patient enrollment benchmarks based on real-world clinical performance data. Each of the initial sponsors will contribute their historical enrollment data, which will be anonymized, aggregated, and made available to all participants via DecisionView's StudyOptimizer for use in benchmarking, planning and forecasting clinical trial enrollment.

"There is a huge demand for clinical performance data to inform and calibrate clinical trial planning," said Alex Lancksweert, Director of Performance & Supplier Governance at GlaxoSmithKline. "Unfortunately, current solutions are not integrated directly into our processes or tools, making it difficult to take advantage of them. We see a lot of value in leveraging the detailed enrollment performance data that already exists in StudyOptimizer to provide planning information at the point of need, in an accessible format."

"We fully support this effort to create the first industry-wide patient enrollment data set for benchmarking purposes," said Henk de Wilde, Global Head Information Management for Clinical Operations at Roche. "Organizations like Roche already have large, existing internal data sets available, but this internal data doesn't allow us to compare our performance to the rest of the market. And DecisionView is uniquely positioned to lead this initiative, since so many of the industry's leading life science firms already have their enrollment data hosted on StudyOptimizer."

Why An Enrollment Benchmarks Data Set?

There is significant demand for trusted clinical trial performance data across a number of different clinical operations processes, including patient enrollment, site selection, budgeting, and clinical supply. In particular, more accurate patient enrollment benchmark data promises to significantly reduce clinical trial delays and cost overruns. Traditional sources for this type of benchmark information include company internal study data, third party data sets, and survey-based benchmarks.  But capturing and maintaining this type of data over time can be challenging, for a number of reasons:

  • lack of data granularity (e.g. ability to segment the data by patient population, inclusion/exclusion criteria, etc,),
  • inconsistent data collection,
  • lack of data breadth/scope/coverage across multiple therapeutic areas and geographic regions
  • no integration with planning processes and tools,
  • infrequent updates
  • significant cost

Because of these challenges, a number of DecisionView's customers asked the company to coordinate an effort to aggregate and share the clinical enrollment data that already exists in the StudyOptimizer product.

DecisionView Enrollment Benchmarks™

In response, DecisionView has announced a new product called DecisionView Enrollment Benchmarks, a set of metrics based on real-world clinical performance data aggregated from DecisionView customers. In order to access the data set, customers must agree to contribute their enrollment data, which will be aggregated and anonymized to ensure the confidentiality of sponsor studies. The breadth and depth of studies in the Enrollment Benchmarks data set will grow as participating sponsors complete additional studies, and as new contributors add their portfolios of completed trial data.

The benefits of DecisionView's approach to aggregating enrollment benchmarks include:

  • Trusted Data – because the data is collected through StudyOptimizer and has been mapped to their data definitions, sponsors understand how it is defined and gathered
  • Planning Support – the rich set of clinical performance data informs and calibrates both initial clinical trial planning and trial rescue/recovery planning
  • Just-In-Time Data - provides planning information at the point of need, in an easily-accessible format
  • New Markets - provides benchmark information where sponsors have little or no prior experience – new indications or new countries
  • Actionable - provides study teams, not just senior management, with a prospective capability to affect improved performance

ABOUT DECISIONVIEW

DecisionView develops innovative web-based software solutions that enable life sciences organizations around the world to improve clinical trial performance. DecisionView's flagship solution, StudyOptimizer, helps organizations optimize clinical trial enrollment by aggregating patient recruitment data from multiple sources and providing analytics, visualizations, and predictive scenario modeling that delivers unique and actionable insight. StudyOptimizer is used by 8 of the top 10 global pharmaceutical companies, and has been used on over 1,250 clinical studies with over 450,000 subjects enrolled in 13 different therapeutic areas across 91 different countries. Investors in the company include Granite Ventures and Aeris Capital. For additional information about DecisionView, go to http://www.decisionview.com or call 415-538-1800.


'/>"/>
SOURCE DecisionView Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. DecisionView Launches StudyOptimizer(TM) 4
2. A Quiet Healing Environment Created by Nurse Call?
3. Someone With Opens its Doors to Create Online Marketplace for Breast Cancer Products and Services
4. Johnson & Johnson and Synthes Announce Definitive Merger Agreement to Create Worlds Most Innovative and Comprehensive Orthopaedics Business
5. MedVantx and Blue Cross & Blue Shield of Rhode Island Partner to Provide Physicians with Integrated Medication Management Platform in Newly Created Patient-Centered Medical Homes
6. Six Health Plans Pay $1.5 Million in Incentives to Create Medical Homes for Nearly Half a Million Hudson Valley Residents
7. Software Development Firms New Intellectual Property Group, Blue Horseshoe IP Creates Solutions to Help Customers Optimize Supply Chain
8. Virtual Radiologic and Lakeland Radiologists Partner to Create Lakeland Radiology Alliance
9. New Ad Campaign: Secret Provision Raises Taxes on Prescription Drug Benefits, Creates Conflict of Interest
10. Novo Nordisk Creates First Mobile Application to Help Doctors Diagnose Bleeding Disorders
11. Exagens Corporate Expansion Creates Job Opportunities in New Mexico
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Bernstein Liebhard LLP today announced that a securities class ... for the District of Arizona on ... or entities who purchased common shares of Insys Therapeutics Inc. ... 3, 2015 through January 25, 2016 (the "Class Period").  The ... of the Securities Exchange Act of 1934.  ...
(Date:2/4/2016)... , Feb. 4, 2016 Global Immunology ... market to drive long-term market growth Summary ... set of chronic disorders that affect 5–7% of ... terms of their symptoms and key patient demographics, ... of immune pathways and an inappropriate immune response. ...
(Date:2/4/2016)... SPRING, Md. , Feb. 4, 2016 In ... Califf , the FDA,s Deputy Commissioner for Medical Products and ... action plan to reassess the agency,s approach to opioid medications. ... epidemic, while still providing patients in pain access to effective ... The FDA will: , Re-examine the risk-benefit paradigm ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... At its annual meeting held last ... Chairman of the National Board of Directors. Mr. McDermott succeeds former APDA Chairman, Fred ... Leslie A. Chambers , APDA President and CEO. “Pat has tirelessly served APDA ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Stuart ... tattoo technology, the PicoSure. Designed to provide the most effective tattoo removal today, Dr. ... with unmatched results. , Developed by Cynosure, the PicoSure has been approved by the ...
(Date:2/5/2016)... ... February 05, 2016 , ... Colorize is ... one drop zone to the next using Colorize's dynamic moving camera. Colorize is perfect ... package includes a 3D slideshow environment with 1 to 5 focus points per scene, ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Health and wellness ... relevant to individuals in the event they are experiencing an illness. Migraines are a ... Americans that are afflicted with migraines would not wish the pain on their worst ...
(Date:2/5/2016)... ... 2016 , ... On June 9-10, Las Vegas will host ... (CME) event presented by the Association for Comprehensive Care in Rare Diseases (ACCORD). ... mission is to provide education, tools, and resources to primary care clinicians that ...
Breaking Medicine News(10 mins):